Occudo Quantitative Strategies’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,012
Closed -$528K 778
2025
Q2
$528K Buy
+2,012
New +$490K 0.06% 345
2023
Q3
Sell
-2,121
Closed -$440K 1158
2023
Q2
$440K Buy
+2,121
New +$411K 0.05% 597
2022
Q4
Sell
-5,484
Closed -$965K 1187
2022
Q3
$965K Sell
5,484
-4,930
-47% -$1.01M 0.08% 410
2022
Q2
$2.1M Buy
10,414
+3,364
+48% +$717K 0.17% 172
2022
Q1
$1.6M Sell
7,050
-8,148
-54% -$1.92M 0.13% 235
2021
Q4
$4.1M Buy
15,198
+760
+5% +$188K 0.36% 46
2021
Q3
$3.49M Buy
14,438
+8,989
+165% +$2.27M 0.42% 25
2021
Q2
$1.29M Buy
+5,449
New +$1.24M 0.2% 144
2021
Q1
Sell
-4,041
Closed -$707K 848
2020
Q4
$707K Buy
+4,041
New +$698K 0.22% 129

Other funds holding LH

Occudo Quantitative Strategies's LH Position: Q3 2025 in Review

Occudo Quantitative Strategies sold out of Labcorp (LH) in Q3 2025, closing a stake of 2,012 shares — an estimated $528K sold.

Occudo Quantitative Strategies first reported a position in LH in Q4 2020 and held it in 9 quarters. The position peaked at $4.1M in Q4 2021. 1,010 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Occudo Quantitative Strategies reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 2,012 Labcorp shares in Q3 2025, an estimated $528K.
  • Occudo Quantitative Strategies first reported a position in Labcorp in Q4 2020 and held it in 9 quarters.
  • Occudo Quantitative Strategies's Labcorp position peaked at $4.1M in Q4 2021.
  • 1,010 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.